Trial intelligence / Profile preview

Intertransverse Process Block - Single or Multiple Injection?

2022-501312-34-01Phase 4Completed

Sponsor
Zealand University Hospital
Start
Jan 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Zealand University Hospital. Primary endpoint: Number of anaesthetised thoracic dermatomes. Started Jan 2023; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2022-501312-34-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2022-501312-34-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call